Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Migalastat Extension Study in Fabry Disease
NCT02194985Phase 3Completed
- Sponsor
- Amicus Therapeutics
- Start
- Mar 2015
- Primary completion
- Oct 2019
- Modality
- Classical Binding Small Molecules
- Countries
- 15
01
Overview
A Phase 3 trial of migalastat in Fabry disease (FD), sponsored by Amicus Therapeutics. Started Mar 2015; status: completed.
02
Drugs
migalastat
03
Conditions
Fabry disease (FD)
Beyond the preview
Go deeper on NCT02194985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194985.